Skip to main content

Table 7 Distribution of the study population according to methylation level of the CpG located in the enhancer

From: Case–control study of HLA-G promoter methylation status, HPV infection and cervical neoplasia in Curitiba, Brazil: a pilot analysis

CpG (enhancer)*

Cases

Controls

 

N = 96

N = 76

 

N

%

N

%

Mean methylation <33 %

37

38.5

40

52.6

Mean methylation >33 %

59

61.5

36

47.4

  1. *CpG site position 598 (GenBank: J03027.1).
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us